MeiraGTx Holdings plc (MGTX) Investor Relations Documents

MeiraGTx Holdings plc (MGTX) investor relations documents from the company's IR site: 4 presentations, 5 press releases; latest deck 2025-10-21. Read in-app with summaries. First-party data.

MeiraGTx CEO Zandy Forbes at Chardan’s 9th Annual Genetic Medicines Conference October 21, 2025 — MeiraGTx CEO Zandy Forbes presented at Chardan's 9th Annual Genetic Medicines Conference on October 21, 2025, regarding the company's gene therapy pipeline.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-07-07Press releaseMeiraGTx Announces $400 million Strategic Investment by Oberland Capital to Support Development and Commercialization of
2026-04-16Press releaseMeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (bota-vec) for the Treatment of X-linked Retinitis Pigm
2026-04-16Press releaseMeiraGTx Announces Positive Three-year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grad
2026-04-14Press releaseMeiraGTx to Present 3-Year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Radiat
2026-03-26Press releaseMeiraGTx Announces FDA Breakthrough Therapy Designation for AAV2-hAQP1 for the Treatment of Grade 2 and Grade 3 Radiatio
2025-10-21Investor meetingMeiraGTx CEO Zandy Forbes at Chardan’s 9th Annual Genetic Medicines Conference October 21, 2025
2025-05-14Investor meetingMeiraGTx CEO Zandy Forbes Fireside Chat at the Bank of America Securities 2025 Healthcare Conference
2025-04-29Investor meetingMeiraGTx CEO Zandy Forbes at Chardan’s “Data & Regulatory Catalysts – Navigating an Evolving Landscape&
2024-10-09PresentationMeiraGTx at 2024 Society for Neuroscience Conference: Potential Treatment for Obesity Caused by MC4R Genetic Deficiency

MGTX overview · MGTX earnings · MGTX financials · MGTX KPIs · MGTX ownership · MGTX peers · MGTX filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.